Funder
Gobierno de España Ministerio de Ciencia e Innovación
CIBER
Reference76 articles.
1. Pharmacokinetics of the fluoropyrimidines: implications for their clinical use;Myers;Cancer Treat. Rev.,1976
2. 5-fluorouracil: mechanisms of action and clinical strategies;Longley;Nat. Rev. Cancer,2003
3. Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells;Wohlhueter;J. Cell. Physiol.,1980
4. Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole;Curtin;Cancer Res.,1991
5. 5-fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development;Grem;Investig. New Drugs,2000